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A B S T R A C T
For the sake of improving patient compliance and sustainability of chemotherapy health-
care system, both TC and CoQ10 were formulated as solid lipid nanoparticles (SLNs). The
study was focused on establishing and validating a simple and reproducible spectropho-
tometric method for simultaneous determination of TC and CoQ10 in their binary mixture
or pharmaceutical dosage forms. A new method based on simultaneous estimation of drug
mixture without prior separation was developed.Validation parameters were checked with
International Conference on Harmonization (ICH) guidelines. The accuracy and reproduc-
ibility of proposed method was statistically compared to HPLC. The TC and CoQ10 were
quantified at absorptivity wavelengths of 236 nm and 275 nm, respectively. Calibration curves
obeyed Beer’s law in range of 2–14 μg/ml with a correlation coefficient (R2) of 0.999 in both
methanol and simplified simulated intestinal fluid (SSIF). The %means recovery of TC and
CoQ10 in pure state or binary mixture at various concentration levels were all around 100%.
The low values of SD and %RSD (<2%) confirm high precision and accuracy of the pro-
posed method. Formulated SLNs showed different %means recovery in range 81–92% for
TC and 32–59% for CoQ10. The data obtained by applying simultaneous Vierordt’s equa-
tions showed no statistical significance in comparison to HPLC. Vierordt’s method was
successfully applied as a simple, accurate, precise, and economical analysis method for es-
timating TC and CoQ10 concentrations in pure state, binary mixture and pharmaceutical
dosage forms.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical
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Imbalance between antioxidants and reactive oxygen species
(ROS) results in oxidative stress, leading to cellular damage.
The ROS plays a major role in causing mitochondrial changes
linked to cancer and metastasis [1,2].
Tamoxifen citrate (TC) is an important non-steroidal es-
trogen antagonist drug that adheres to all stages of estrogen
receptor positive breast cancer treatment as well as long-
term prophylactic therapy in high-risk and post-menopausal
women [3]. However, uptake of antioxidants by tissue to reduce
ROS production could be instrumental in controlling cancer [4].
Coenzyme Q10 (CoQ10) is a proven potent antioxidant and pro-
tective agent against many diseases including cancer [5]. It was
recorded that prescribing vitamins (C and E), essential fatty
acids, and CoQ10 for those patients receiving TC allows for
cancer enhancing treatment outcomes and improves chemo-
therapy tolerability [6].
For the sake of improving patients’ compliance with long
term medication and sustainability of healthcare system, we
were interested in formulating a new drug delivery system
loaded with both drugs. Simple and fast simultaneous esti-
mation of drug concentrations in their mixture or therapeutic
delivery systems is posing a real challenge to formulators. Re-
cently, many estimation techniques were developed on raw
overlapping spectral data to enable mixture resolution, such
as different order derivatives [7–9], derivatives of the ratio spec-
trum [10,11] and ratio subtraction technique [12]. Valuable
researches were published based on using simultaneous equa-
tion (Vierordt’s method) for estimation of 2 or more drugs in
combined mixtures or pharmaceutical dosage forms [13–16].
Extensive literature survey revealed that no spectrophoto-
metric method is available for simultaneous determination of
TC/CoQ10 mixture. Despite the numerous advantages of HPLC
for simultaneous determination of different drug mixture,most
official methods suffered fromwell-established drawbacks such
as: high solvent cost, low resolution power columns, long run
time, difficult selection of column packing materials, use of the
gradient elution, limited choice of detectors, base-line drift on
varying the eluent, lower signal-to-noise and signal-to-
background ratios and increased instrument complexity [17].
Additionally, chemical and physical properties of TC and CoQ10
revealed very big difference in their polarity and partition co-
efficients [18,19]. Hence, the current study was focused on
establishing and validation of Vierordt’s method for spectro-
photometric determination of TC and CoQ10 concentrations
in their binary mixture or pharmaceutical dosage forms. The
accuracy and precision of the proposed method were con-
firmed by HPLC measurement. Student’s paired t-test was
applied to compare the values of %means drug recovery by the
two analytical methods.
2. Materials and methods
2.1. Materials
Tamoxifen citrate (m.wt: 563.62) was generously given as a
gift by Medical United Pharmaceutical Company, Cairo, Egypt.
CoenzymeQ10 (m.wt: 863.34) and lecithin were given as gifts
fromAmriya Company for Pharmaceutical Industries, Rushdie,
Alexandria, Egypt. Labrafac (capryl/caprylic triglycerides) was
kindly donated by Gattefosse Company, France. Stearic acid,
sodium lauryl sulfate (SLS), methanol, sodium dihydrogen
phosphate (NaH2PO4), isopropyl alcohol, Tween 20, sodium
chloride (NaCl) and sodium hydroxide (NaOH) were pur-
chased from EL-Gomhoria Company, Cairo, Egypt.The n-hexane
and triethylamine were also obtained from Sharlu (Spain)
and Sigma Aldrich (Germany), respectively. All other chemi-
cals were of analytical grade. Distilled water was used
throughout the study.
2.2. Equipment
Mechanical stirrer (IKAWorks,Asia Sdn. Bhd., Malaysia), cooling
centrifuge (Hermle Z 200A, Germany), hot plate stirrer (Jenway
1000, U.K) and analytical balance (Setra BL-410S, U.S) were used.
A JASCO V-530 double beam UV-VIS spectrophotometer with
a fixed slit width (2 nm) connected to a computer loaded with
spectra manager program was applied for spectral acquisi-
tion and elaboration of the data obtained. Quartz cuvettes, 1-cm
path length were used for measuring the light absorption in
ultra-violet region (200–400 nm). Shimadzu HPLC model 20A
auto sampler (Japan), UV detector and quaternary pump system
with auto-gasser were used for HPLC separation and estima-
tion of drug concentrations.
2.3. Methods
Both TC and CoQ10 are poorly soluble drugs (Fig. 1A and B).
Methanol and simplified simulated intestinal fluid (SSIF) were
chosen as dissolution media to ensure complete solubility of
both drugs. The SSIF was prepared according to Taupitz et al.
[20]. Blank SSIF (pH 6.5) was prepared by dissolving 3.438 g
NaH2PO4 and 6.186 g of NaCl in 900 ml of distilled water. The
pH was adjusted with 0.1 N NaOH solution. The SSIF was
reached by adding 0.25% w/v SLS and Tween 20. The volume
was adjusted to 1000 ml by isopropyl alcohol. The buffer so-
lution was ultrasonicated for 15 min then stirred for
another15 min.
2.3.1. Preparation of sample solutions of drugs mixture
Alcoholic sample solution of TC and CoQ10 binary mixture was
prepared at lab-ratio of 5:5. A 0.5 ml of standard working so-
lutions (100 μg/ml) of each drug was transferred to 10 ml
volumetric flask and the volume was completed to the mark
with methanol to obtain sample solution of 5 μg/ml concen-
tration for each drug. The same procedure was followed with
SSIF at strength ratio 10:10 to get sample solution of 10 μg/ml
for each drug.
2.3.2. Preparation of TC/CoQ10 loaded solid lipid
nanoparticles
In order to validate the developed simultaneous equations for
estimating TC and CoQ10 concentrations in a pharmaceuti-
cal dosage form, solid lipid nanoparticles (SLNs) were chosen
as a novel drug delivery system [21]. The SLNs offer unique
properties such as small size, large surface area, and high drug
loading [22]. The SLNs were prepared by micro-emulsification
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followed by ultrasonication technique (Fang et al.) [23]. Stearic
acid (2%, w/v) was melted at 60–70 °C. Accurate weights of
CoQ10 and TC were dispersed in lipid melt to have homog-
enous drug–lipid mixture. Lipid melt was added to aqueous
surfactant solution (3%, w/v P188) preheated 10 °C above the
melting point of the lipid. Emulsification process was done
under stirring by a high-speed mechanical stirrer at 6000 rpm
for 10 min. Finally, the formed crude emulsion was
ultrasonicated using a probe for 10 minutes to prevent crys-
tallization of lipids and minimize particle size. The obtained
nanoemulsion was cooled to room temperature to allow for-
mation of SLNs dispersion. Separation of SLNs was carried out
by centrifugation at 17,000 rpm for 30 min. The supernatant
was discarded and sediment was washed with cold distilled
water with repeating centrifugation process.Amixture of stearic
acid with lecithin or labrafac was applied for preparing other
formulae of SLNs following the previous procedures. A speci-
fied weight of each formula was dissolved in methanol for
subsequent determination of drug concentrations in a phar-
maceutical dosage form [24].
2.3.3. Development and validation of simultaneous
spectrophotometric method for estimating TC and CoQ10
concentrations in pure state, binary mixture and SLNs
Firstly, working solutions of both drugs in pure state were
scanned separately in UV range 200–400 nm against blanks for
determining maximum wavelengths (λmax). The λmax were
236 nm and 275 nm for TC and CoQ10, respectively (Fig. 2).
Vierordt’s spectrophotometric method applied for simultane-
ous estimation of drugs that have measurable absorbance at
λmax of each other [25]. For preparing calibration curves, serial
solutions (2–14 μg/ml) of each drug were prepared using their
working solutions. The absorbance was measured in tripli-
cate at λmax 236 and 275 nm. For linearity studies, calibration
curves for TC and CoQ10 were plotted. Values of molar ab-
sorptivity of both drugs were determined by reconstructing the
calibration curves using drugs molar concentrations. The re-
gression equations, molar absorptivity and optical parameters
are presented in Table 1.
Two simultaneous equations for determining drug concen-
trations in their mixture were developed using their molar
absorptivity coefficient values (Eqs. 1 and 2).
CTC =
A A1 2 2 1
1 2 2 1
β β







A A2 1 1 2
1 2 2 1
α α
α β α β (2)
where CTC and CCoQ10 are concentrations of TC and CoQ10, re-
spectively, in their sample solution (mole/L). A1 and A2 are
absorbances of laboratory prepared mixtures at 236 nm and
275 nm, respectively. The α1 and α2 are molar absorptivities of
TC at 236 nm and 275 nm, respectively. However, β1 and β2 are
molar absorptivities of CoQ10 at 236 nm and 275 nm, respec-
tively. All validation procedures were performed in accordance
with International Conference on Harmonization ICH Q2 (R1)
guideline [26]. To validate Vierordt’s formula on the working
solutions of TC and CoQ10, the %means recovery (±SD) and
%relative standard deviations (%RSD) at two concentration levels
for each drug (8 and 12 μg/ml) in their pure state were calcu-
lated. Precision of the developed method was also ascertained
by repeatability and intermediate precision studies.The in intra-
day study (repeatability) of the proposedmethod was performed
with a minimum of three replicate measurements. The con-
centrations of the two drugs were calculated every two hours
(0, 2, and 4 h). In inter-day (intermediate precision) study,
the concentrations of drugs were calculated on three
)A( (B)
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Fig. 2 – Overlay spectrum of tamoxifen citrate and
coenzyme Q10 mixture wavelength scan.
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consecutive days. The results of data statistical analysis are
given in Table 2. Limit of Detection (LOD) and Limit of Quan-
tification (LOQ) were also calculated. The LOD is the lowest
amount of analyte, which can be detected but not necessar-
ily quantitated as an exact value (Eq. 3). The LOQ is the lowest
amount of analyte,which can be quantitatively determined with
suitable precision and accuracy (Eq. 4).
LOD S= ×3 3. σ (3)
LOQ S= ×10 σ (4)
where ‘σ’ is the standard deviation of the response and ‘S’ is
the slope of the calibration curve. The results of LOD and LOQ
for TC and CoQ10 are shown in Table 2.
Secondly, developedVierordt’s simultaneous equations (Eqs.
1 and 2) were applied for determining TC and CoQ10 concen-
trations in their lab mixtures of methanol and SSIF and SLNs.
Parameters of accuracy and precision were also determined to
validate developed simultaneous equations used for deter-
mining the concentrations of drugs in their binary mixture or
pharmaceutical dosage forms (Tables 3, 4; respectively).
2.3.4. HPLC as a reference method for determining drug
concentrations
The content of TC and CoQ10 (pure state or SLNs) was deter-
mined by HPLC as confirmatory reference test for evaluating the
developedVierordt’s spectrophotometric method for direct es-
timation of drug concentrations without prior separation.
Reference analysis method was performed by Shimadzu chro-
matographic systemwhere reverse phase columnC18 phenomax
150 mm × 4.6 mm, with a porosity 5 × 10−3mm, was used as a
stationary phase.The logP for both drugs was reported to be 6.3
and 17.16, whereas polar surface area was 145 and 52.6 for TC
and CoQ10, respectively [18,19]. This vast difference in physi-
cochemical properties was expected to make chromatographic
separation of TC and CoQ10 from their mixture by one elution
system in short retention time with maximum recovery, pre-
cision and repeatability very hard or nearly impossible. Hence
two mobile phases with different natures were chosen, a polar
mobile phase for separation ofTC and a non-polar mobile phase
for separation of CoQ10. A mixture of tri-ethylamine acetate
buffer:methanol with a ratio of 24.3:75.7 v/v was found to be
optimal for TC separation [27]. Methanol:n-hexane with a ratio
of 65:35 v/v was used for CoQ10 separation [28]. The injection
volume was 50 μl with flow rate 1.5 ml/min and UV detection
of both drugs was carried out at 275 nm (Figs. 3 and 4).
Accurately weighed 10 mg of TC or CoQ10 were trans-
ferred to 100 ml volumetric flasks (stock solutions). Both drugs
were dissolved in 25 ml methanol, and volume was made up
to mark with suitable mobile phase. Serial dilutions were made
in concentration range of 2–14 μg/ml for each drug.Values ob-
tained were used to build calibration models and to assess
predictive capacity of models. Recovery studies were
Table 1 – Linearity regression equations and molar absorptivity values for TC and CoQ10 calibration curves at chosen







max (nm) Linear egression
equations
Slope Intercept R2 Molar absorptivity
values
Methanol TC 2–14 μg/ml 236 A – 0.01 0.999 15332
275 A – 0.01 0.999 10580
CoQ10 236 A – 0.01 0.999 30340
275 A – 0.025 0.999 76714
SSIF TC 236 A – 0.02 0.999 21128
275 A – 0.0006 0.999 10701
CoQ10 236 A – 0.0027 0.999 28749
275 A – 0.0073 0.9999 68389
Table 2 – Validation sheet for determination of TC and CoQ10 in their pure forms, by applying Vierordt’s
spectrophotometric method.
TC CoQ10
Methanol SSIF Methanol SSIF
Accuracy At conc. level 8 μg/ml % Mean recovery ± SD 100.14 ± 0.9 99.44 ± 1.6 99.69 ± 1.0 100.34 ± 0.7
%RSD 0.987 1.55 1 0.682
At conc. level 12 μg/ml % Mean recovery ± SD 99.97 ± 0.8 98.54 ± 1.6 100.54 ± 0.4 101.32 ± 1.3
%RSD 0.829 1.547 0.379 1.269
Precision Repeatability (%drug recovery) ± SD
0 h 100.36 ± 1.7 100.1 ± 0.7 100.03 ± 0.8 100.19 ± 0.7
2 h 100.92 ± 0.6 99.9 ± 0.8 98.8 ± 0.9 101.8 ± 0.8
4 h 99.8 ± 0.8 97.8 ± 1 100.28 ± 1.1 99.9 ± 0.6
Intermediate precision (%drug recovery) ± SD
1st day 101.2 ± 1.2 99.9 ± 1.9 100 ± 0.5 100.24 ± 1.1
2nd day 100.1 ± 0.9 99.8 ± 0.2 98.5 ± 0.8 101.4 ± 0.9
3rd day 100.6 ± 0.6 100.8 ± 1.1 99.6 ± 0.8 100 ± 0.8
LOD (μg/ml) 0.088 0.043 0.054 0.1
LOQ (μg/ml) 0.26 0.14 0.16 0.3
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performed on a couple of concentrations of 8 and 12 μg/ml.The
%recovery (±SD) and %relative standard deviations (%RSD) were
calculated (Table 5).
HPLCmethod was also applied for determining drug content
in samples of SLNs.Weighted 50 mg of SLNs was dissolved in
each mobile phase and injected into HPLC column to esti-
mate the amount of TC or CoQ10 loaded in SLNs.The accuracy
and precision were also performed (Table 6).
2.3.5. Statistical analysis
All data were expressed as mean (±SD). Data were analyzed
using the program SPSS 16.0 (SPSS Inc., Chicago, IL, USA) with
help of paired samples T where P < 0.05 was conducted as sig-
nificance level.
3. Results and discussion
3.1. Linearity
Calibration curves of TC and CoQ10 at 236 nm and 275 nm in
methanol and SSIF media showed high linearity. The correla-
tion between sample concentrations and their absorbencies
complied with Beer’s law as illustrated by high values of
Table 3 – Validation sheet for determination of TC and CoQ10 in their binary mixture at different dissolution media, by
applying Vierordt’s spectrophotometric method.
Parameter Methanol SSIF
TC CoQ10 TC CoQ10
Drug concentration (μg/ml) Theoretical 5 5 10 10
Recovered 4.92 5.06 9.99 10
Accuracy %Mean recovery ± SD 98.4 ± 0.3 101.16 ± 0.2 99.44 ± 1.6 100.34 ± 0.7
%RSD (SD100/x) 0.32 0.21 1.546 0.67
% %Error RSD
n( ) 0.569 0.577 0.8925 0.387
Precision Repeatability (%drug recovery) ± SD
0 h 100.36 ± 1.7 100.03 ± 0.8 100.14 ± 1 100.14 ± 1
2 h 101.36 ± 0.7 99.6 ± 0.5 100.51 ± 1.9 98.36 ± 1.1
4 h 100.48 ± 1.5 100.3 ± 1.7 100.38 ± 0.9 99.36 ± 1.7
Intermediate precision (%drug recovery) ± SD
1st day 101.2 ± 1.2 99.94 ± 1.9 100.14 ± 1 100.14 ± 2
2nd day 100.36 ± 1.2 100.26 ± 0.7 100.36 ± 1.7 99.36 ± 1.6
3rd day 100.35% ± 0.5 99.86 ± 0.8 100.36% ± 1.7 100.21% ± 1.3
Table 4 – Validation sheet for determination of TC and CoQ10 in their SLNs dosage form, by applying Vierordt’s
spectrophotometric method.
Parameter SLNs (SA) SLNs (SA/lecithin) SLNs (SA/Labrafac)
TC CoQ10 TC CoQ10 TC CoQ10
Claimed amount (mg) 10
Recovered amount (mg) 8.7 3.8 8.1 4.8 9.2 5.9
%Average accuracy (±SD) 870.6 0.5 81 ± 0.8 48 ± 0.6 92 ± 0.4 59 ± 1.5
%RSD 0.57 0.437 0.79 0.6 0.4 1.49
%Error 0.32 0.27 0.39 0.37 0.25 0.65
Repeatability (±SD) 99.40.8 980.7 990.1 990.7 99.40.7 990.04
Intermediate Precision (±SD) 981.3 971.2 990.3 1000.4 1000.3 1010.06
SA = Stearic acid.
Table 5 – Recovery studies by HPLC method for pure drugs.
TC C0Q10
Accuracy At conc. level 8 μg/ml % mean recovery ± SD 99.99 ± 0.1 101.43% ± 1.1
%RSD 0.13 1
At conc. level 12 μg/ml % mean recovery ± SD 100.04 ± 0.2 99.66% 0.42
%RSD 0.22 0.421
Precision Repeatability (%drug recovery) ± SD
0 h 99.7 ± 0.5 100.03 ± 0.8
2 h 100.2 ± 0.6 98.8 ± 0.9
4 h 99.8 ± 0.8 100.28 ± 1.1
Intermediate precision (%drug recovery) ± SD
1st day 101.2 ± 1.2 100 ± 0.5
2nd day 100.1 ± 0.9 98.5 ± 0.8
3rd day 100.6 ± 0.6 99.6 ± 0.8
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regression coefficients (R2 ≈ 0.999) and small values of inter-
cepts (Table 1).
3.2. Development of Vierordt’s equations for
simultaneous estimation of TC and CoQ10
The spectral overlapping between spectral graphs of TC and
CoQ10 (Fig. 2) was sufficient to demonstrate that direct spec-
trophotometric measurements cannot be applied for
simultaneous determination of the two drugs in their mixture
without prior separation.Two simultaneous equations for cal-
culating TC and CoQ10 concentrations in their binary mixture
were developed using molar absorptivity coefficient values.The




















where A1 and A2 are the absorbance value at 236 and 275 nm,
respectively, and C is the concentration in mole/l. Once ab-
sorptivity values are determined, very little time is required
for calculating drug concentrations using the absorbances of
samples at two selected wavelengths. Employing simultane-
ous equation is a very simple method and can be employed
for a routine analysis of TC and CoQ10.
3.3. Validation of Vierordt’s simultaneous equations
3.3.1. For drugs in pure state
The accuracy of an analytical method is the closeness of test
results to that of true values [29]. In order to ensure reliabil-
ity of proposed method, accuracy was confirmed by recovery
studies at two concentration levels (8 and 12 μg/ml). The
%means recovery ofTC and CoQ10 were 98.54–100.14 and 99.69–
101.32, respectively, indicating the accuracy of the method
(Table 2). The low values of SD and %RSD (<2%) are another
confirmatory parameters for high precision, reproducibility and
accuracy of proposed method (Table 2).The %RSD for TC at the
two concentration levels was between 0.829–0.987 and 1.547–
1.55 in methanol and SSIF, respectively. Moreover, %RSD at 8 μg/
ml was 1 and 0.682 for CoQ10 inmethanol and SSIF, respectively,
and was 0.379 and 1.269 at concentration level of 12 μg/ml in
methanol and SSIF, respectively.
Precision study was also established by measuring absor-
bance of sample solution without changing the assay procedure
at different time intervals. It is clearly obvious that the pro-
posed method was highly precise, due to high %recovery
presented in Table 2 (100.03–102% for intra-day and 98.46–
102.4% for inter-day measurements). The LOD was 0.088 μg/
ml and 0.043 μg/, while LOQ was 0.26 μg/ml and 0.142 μg/ml
for TC in methanol and SSIF, respectively. The LOD for CoQ10
was 0.16 μg/ml and 0.1 μg/ml, whereas LOQ was 0.16 μg/ml and
0.3 μg/ml in methanol and SSIF, respectively (Table 2).
3.3.2. For drugs in lab mixtures
The developed method was also successfully applied for de-
termination of TC and CoQ10 in their binary mixture solution
at different ratio strengths. In methanol, the concentration ratio
5:5 μg/ml, showed %means recovery 98.4% ± 0.32 for TC and
101.2% ± 0.21% for CoQ10. Meanwhile, 99.9% ± 0.63% and
100.3% ± 0.39% were %means recovery for TC and CoQ10, re-
spectively, in SSIF at concentration ratio 10:10 μg/ml. Both %RSD
and %error were less than 2%, indicating high accuracy of the
developed method. The results also ensured high repeatabil-
ity and intermediate precision (Table 3).
3.3.3. For drugs loaded in SLNs
The SLNs were prepared loaded with 10 mg of each drug. The
%means recovery of each drug was determined by applying the
developed equations.The results showed high agreement with
the loaded amount of drugs (estimated %means recovery was
81–92% forTC and 32–59% for CoQ10).The SD, %RSD and %error
were less than 2, confirming the method’s accuracy (Table 4).
The developed method for simultaneous estimation of TC and
CoQ10 loaded in SLNs was valid, applicable, and with high re-
peatability and intermediate precision.
Table 6 – Results of HPLC method for estimating of drugs content in SLNs.
Parameter SLNs (SA) SLNs (SA/lecithin) SLNs (SA/Labrafac)
TC CoQ10 TC CoQ10 TC CoQ10
Claimed amount (mg)
Recovered amount (mg) 8.7 3.2 8.6 5 9 6.2
%Average accuracy (±SD) 870.6 0.5 86 ± 0.07 50 ± 0.1 90 ± 0.08 62 ± 0.06
%RSD 0.57 0.437 0.068 0.1 0.078 0.06
%Error 0.32 0.27 0.039 0.057 0.045 0.034
Repeatability (±SD) 99.940.9 980.7 99.90.1 990.7 99.40.7 990.04
Intermediate precision (±SD) 981.3 1000.9 990.3 1000.4 1000.3 1010.06
SA = Stearic acid.
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3.4. HPLC as a reference method
In HPLC method, an adequate separation of eluted com-
pounds was optimized. Several aliquots of standard solutions
ofTC and CoQ10 at 2–14 μg/ml range were prepared withmobile
phases. The optimum wavelength for detection of both drugs
was 275 nm. The peak shapes of both drugs were symmetri-
cal (Fig. 3 and 4).The average retention times for TC and CoQ10
were found to be and 3.2 and 2.6 min, respectively. Con-
structed calibration curves showed high linearly with R2 ≈ 0.999.
Application of HPLC method for pure drugs showed perfect re-
covery values (99.66–101.4%) for both drugs with high precision
(%RSD < 2) (Table 5). Results of HPLC %means recovery from
different formulae of SLNs were presented in Table 6. The
method was accurate and precise as indicated by recovery
studies and % RSD not more than 2%.
Recorded values of %drug recovery from the two analyti-
cal methods were statistically analyzed using student paired
t-test (Table 7). There were no significant differences between
%drug recovery by the developedVierordt’s method and HPLC
method (P < 0.05, at 95% level of significance). Vierordt’s spec-
trophotometric method revealed high degree of accuracy for
estimating TC and CoQ10 in their binary mixture and phar-
maceutical dosage forms.
4. Conclusion
Admitting that HPLC method is expensive in hardware and
chromatographic reagents, simultaneous estimation of two
drugs with different polarity are yet more complex and more
Fig. 3 – Representative HPLC chromatogram of TC using triethylamine acetate buffer:methanol (24.3:75.7, v/v) mobile phase.
Fig. 4 – Representative HPLC chromatogram of CoQ10 using methanol:n-hexane (65:35, v/v) mobile phase.







8 μg/ml 12 μg/ml
TC CoQ10 TC CoQ10 TC CoQ10 TC CoQ10 TC CoQ10
Vierord’s method (%drug recovery) 100.14 99.44 99.97 100.5 87 38 81 48 92 59
HPLC method (%drug recovery) 99.99 101.43 100.04 99.6 87 32 86 50 90 62
Significance value (P < 0.05) 0.443 0.184 0.42 0.225 1 0.74 0.07 0.2 0.19 0.074
SA = Stearic acid.
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expensive. Vierordt’s method was successfully applied for se-
lective routine analysis ofTC and CoQ10 concentrations in their
binary mixture or pharmaceutical dosage forms without prior
separation.The developed method was validated according to
per ICH (Q2R1) guidelines. Recovery studies were satisfactory
with low SD, %RSD, high repeatability and intermediate pre-
cision. Statistical analysis of data revealed no significant
differences between drug concentrations estimated byVierordt’s
method and those obtained by HPLC, confirming accuracy and
precision of the developed method.Vierordt’s method has the
benefits of being simple, rapid, direct, economic, with minimum
data manipulation and not requiring sophisticated tech-
niques or instruments.
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